VF
ATRA icon

Virtu Financial’s Atara Biotherapeutics ATRA Stock Holding History

Virtu Financial’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-739
Closed -$9K – 1401
2023
Q4 		$9K Buy
739
+326
+79% +$7.6K ﹤0.01% 1415
2023
Q3 		$15K Sell
413
-77
-16% -$3.43K ﹤0.01% 1050
2023
Q2 		$20K Buy
+490
New +$27.7K ﹤0.01% 1259
2021
Q3 		– Sell
-507
Closed -$197K – 1491
2021
Q2 		$197K Buy
+507
New +$181K 0.02% 1002
2018
Q3 		– Sell
-299
Closed -$274K – 1527
2018
Q2 		$274K Buy
+299
New +$321K 0.02% 1228

Other funds holding ATRA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return